Literature DB >> 16116258

Differentiation of Candida albicans and Candida dubliniensis using a single-enzyme PCR-RFLP method.

Hossein Mirhendi1, Koichi Makimura, Kamiar Zomorodian, Nobuko Maeda, Tomoko Ohshima, Hideyo Yamaguchi.   

Abstract

Candida dubliniensis is a novel Candida spp. that is similar to Candida albicans with respect to several phenotypic characteristics. However, they differ from each other with respect to epidemiology, pathogenesis, and the rapid development of resistance to fluconazole. In the present study, we used a single-enzyme PCR-restriction fragment length polymorphism (RFLP) technique to differentiate C. dubliniensis from C. albicans. The amplified ITS region of C. dubliniensis was digested once using the enzyme B1nI, whereas that of C. albicans remained intact. All standard strains tested were identified successfully by this method. None of 140 clinical isolates identified morphologically as C. albicans were recognized as C. dubliniensis based on their PCR-RFLP pattern. Our PCR-RFLP method easily differentiated C. dubliniensis from C. albicans, and this result was also demonstrated with standard strains.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16116258

Source DB:  PubMed          Journal:  Jpn J Infect Dis        ISSN: 1344-6304            Impact factor:   1.362


  11 in total

1.  Comparison of PCR-RFLP with 21-plex PCR and rDNA Sequencing for Identification of Clinical Yeast Isolates.

Authors:  Mohammad Kord; Ahmad Elmimoghaddam; Seyed Jamal Hashemi; Sassan Reziae; Roshanak Daie Ghazvini; Mohammadreza Salehi; Alireza Abdollahi; Ali Ahmadi; Muhammad Ibrahim Getso; Teun Boekhout; Sadegh Khodavaisy
Journal:  Mycopathologia       Date:  2021-01-04       Impact factor: 2.574

2.  Molecular phylogenetic analysis of a geographically and temporally matched set of Candida albicans isolates from humans and nonmigratory wildlife in central Illinois.

Authors:  Lauren Wrobel; Julia K Whittington; Claude Pujol; Soon-Hwan Oh; Marilyn O Ruiz; Michael A Pfaller; Daniel J Diekema; David R Soll; Lois L Hoyer
Journal:  Eukaryot Cell       Date:  2008-07-11

3.  Analysis of ALS5 and ALS6 allelic variability in a geographically diverse collection of Candida albicans isolates.

Authors:  Xiaomin Zhao; Soon-Hwan Oh; Robert Jajko; Daniel J Diekema; Michael A Pfaller; Claude Pujol; David R Soll; Lois L Hoyer
Journal:  Fungal Genet Biol       Date:  2007-06-02       Impact factor: 3.495

4.  Chemical composition and antimicrobial activities of the essential oils from three ecotypes of Zataria multiflora.

Authors:  K Zomorodian; M J Saharkhiz; M J Rahimi; A Bandegi; G Shekarkhar; A Bandegani; K Pakshir; A Bazargani
Journal:  Pharmacogn Mag       Date:  2011-01       Impact factor: 1.085

5.  Determination of antifungal susceptibility patterns among the clinical isolates of Candida species.

Authors:  Kamiar Zomorodian; Mohammad Javad Rahimi; Kayvan Pakshir; Marjan Motamedi; Moosa Rahimi Ghiasi; Hasanein Rezashah
Journal:  J Glob Infect Dis       Date:  2011-10

6.  Molecular identification and in-vitro antifungal susceptibility testing of Candida species isolated from patients with onychomycosis.

Authors:  K Pakshir; K Zomorodian; A Zakaei; M Motamedi; M Rahimi Ghiasi; M Karamitalab
Journal:  Curr Med Mycol       Date:  2015-12

7.  Comparison of Enzymatic Method Rapid Yeast Plus System with RFLP-PCR for Identification of Isolated Yeast from Vulvovaginal Candidiasis.

Authors:  Moallaei Hossein; Seied Hossein Mirhendi; João Brandão; Reza Mirdashti; Laura Rosado
Journal:  Iran J Basic Med Sci       Date:  2011-09       Impact factor: 2.699

8.  Synthesis and antifungal activity of benzimidazole, benzotriazole and aminothiazole derivatives.

Authors:  S Khabnadideh; Z Rezaei; K Pakshir; K Zomorodian; N Ghafari
Journal:  Res Pharm Sci       Date:  2012-04

9.  Chemical Composition, Antifungal and Antibiofilm Activities of the Essential Oil of Mentha piperita L.

Authors:  Mohammad Jamal Saharkhiz; Marjan Motamedi; Kamiar Zomorodian; Keyvan Pakshir; Ramin Miri; Kimia Hemyari
Journal:  ISRN Pharm       Date:  2012-12-13

10.  In Vitro Susceptibility and Trailing Growth Effect of Clinical Isolates of Candida Species to Azole Drugs.

Authors:  Kamiar Zomorodian; Azadeh Bandegani; Hossein Mirhendi; Keyvan Pakshir; Navvab Alinejhad; Ali Poostforoush Fard
Journal:  Jundishapur J Microbiol       Date:  2016-02-20       Impact factor: 0.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.